LYEL · Lyell Immunopharma, Inc.
Market Cap
$356.06M
Shares
24.51M
Lyell Immunopharma, Inc. Earnings Call Transcripts
Quarterly earnings calls for Lyell Immunopharma, Inc. (LYEL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q2
2026-08-06
Lyell Immunopharma, Inc. (LYEL) Q2 2026 Earnings Call
Revenue
$4,000
▼ 50% YoY Diluted EPS
$-1.92
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Lyell Immunopharma, Inc. (LYEL) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Lyell Immunopharma, Inc. (LYEL) Q1 2026 Earnings Call
Revenue
$2,000
▼ 71.4% YoY Diluted EPS
$-1.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
Lyell Immunopharma, Inc. (LYEL) Q4 2025 Earnings Call
Revenue
$6,000*
▼ 45.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–4 of 4 earnings calls
Key facts
CIK
1806952
CUSIP
55083R203
13F (30d)
90 filings
85 filers
Visit website
Investor relations